Results 101 to 110 of about 219 (121)

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management

Medicina (Lithuania), 2021
Kiran Motaparthi, Simo Huang, Motaparthi Kiran   +2 more
exaly  

A Review of the Systemic Treatment of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

Biomedicines, 2022
Hua-Ching Chang, Ming-Hsiu Lin, Tsung-Jen Wang   +2 more
exaly  

Stevens‐Johnson Syndrome due to COVID‐19 vaccination

Clinical Case Reports (discontinued), 2021
Nikoo Mozafari
exaly  

Daunorubicin induced Stevens‐Johnson syndrome: A case report

Clinical Case Reports (discontinued), 2021
Preeti Shakya
exaly  

New Grading System and Treatment Guidelines for the Acute Ocular Manifestations of Stevens-Johnson Syndrome

Ophthalmology, 2016
Darren G Gregory
exaly  

Mycoplasma pneumoniae–induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: A systematic review

Journal of the American Academy of Dermatology, 2015
Ilona Frieden, Kanade Shinkai
exaly  

Allopurinol-Induced Stevens–Johnson Syndrome (SJS)

Clinical Pharmacology: Advances and Applications, 2023
exaly  

Clinical, Etiologic, and Histopathologic Features of Stevens-Johnson Syndrome During an 8-Year Period at Mayo Clinic

Mayo Clinic Proceedings, 2010
Michael Camilleri, David Wetter
exaly  

UK guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in adults 2016

Journal of Plastic, Reconstructive and Aesthetic Surgery, 2016
Catherine Smith, Jane Setterfield, Christopher Bunker   +2 more
exaly